This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
LabCorp (LH) Beats on Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Laboratory Corp. of America Holdings (LH) rides high on its Diagnostics business Q2. The raised outlook buoys optimism.
LabCorp (LH) Tops Q1 Earnings, Misses Revenue Estimate
by Urmimala Biswas
LabCorp has a Zacks Rank #4(Sell) but that could change following its first quarter 2017 earnings report which has just released.
Is Laboratory Corp. a Suitable Stock For Value Investors?
by Zacks Equity Research
Let's put Laboratory Corporation Of America Holdings (LH) stock into this equation and find out if it is a good choice for value-oriented investors right now.
LabCorp (LH) Up 3.6% Since Earnings Report: Can It Continue?
by Zacks Equity Research
LabCorp (LH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
LabCorp (LH) Beats on Q4 Earnings & Revenue Estimates
by Zacks Equity Research
LabCorp posted fourth quarter 2016 results with both earnings and revenues beating the Zacks Consensus Estimate.
MedTech Stocks' Q4 Earnings on Feb 16: LH, WST and MDRX
by Zacks Equity Research
Let's take a look at the major MedTech stocks slated to release their fourth-quarter 2016 numbers on Feb 16.
3 Stocks That Beat Earnings and Raised This Week
by Brian Bolan
The beat and raise is music to the ears of the aggressive growth investor.
Lots Happening in MedTech: Should You Buy These Stocks?
by Zacks Equity Research
We have noticed a substantial transformation in the U.S. medical device market of late and it is important for market participants to adapt. We have hit upon3 major evolving trends in this sector.